Analyze Diet
Veterinary ophthalmology2014; 18(6); 443-456; doi: 10.1111/vop.12234

Clinical, histopathological and immunohistochemical characterization of a novel equine ocular disorder: heterochromic iridocyclitis with secondary keratitis in adult horses.

Abstract: To describe the clinical, histopathologic and immunohistochemical characteristics of an equine ocular inflammatory disease resulting in anterior uveitis and corneal endothelial inflammation associated with iris pigment dispersion and retrocorneal fibrous membrane (RFM) formation. Methods: Retrospective study. Methods: Sixteen horses with evidence of pigmented keratic precipitates (KPs), corneal edema, and/or iris depigmentation. Information collected from the medical records included signalment, clinical signs, prereferral treatment duration and response to therapy, ophthalmic examination findings, postreferral treatment, response to therapy, and outcome. Results: Twenty-one eyes from 16 horses were affected. Age ranged between 9 and 25 years (Average 16.1 years). Blepharospasm, epiphora, and/or corneal opacification were the first clinical signs noted. At the time of referral pigmented KPs, corneal edema, iridal depigmentation, and retrocorneal membranes were commonly seen. Treatment included topical and/or systemic anti-inflammatories and antibiotics with variable response. Reduction or cessation of anti-inflammatory therapy resulted in worsening of clinical signs and disease progression. Eight eyes ultimately required enucleation. Histopathology changes include iridal pigment loss and dispersion, RFM formation, and keratitis. Variable degrees of lymphoplasmacytic inflammation were dominated by T-cells within the corneal stroma, RFM, iris, and ciliary body with occasional multinucleated giant cells. Conclusions: Heterochromic iridocyclitis with secondary keratitis (HIK) is characterized by uveal inflammation with pigment dispersion and suspected corneal endothelial dysfunction. Horses being treated for HIK require diligent and frequent follow-up examinations in combination with aggressive local immune suppression to control the disease. However, HIK may not respond to therapy and enucleation may ultimately be required to ensure the horse's comfort.
Publication Date: 2014-11-17 PubMed ID: 25399915DOI: 10.1111/vop.12234Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explored a novel equine ocular disorder, known as heterochromic iridocyclitis with secondary keratitis (HIK), characterizing its clinical presentation and the corresponding pathological and immunological features. The study found that horses with HIK show signs of anterior uveitis and corneal endothelial inflammation along with iris pigment dispersion and retrocorneal fibrous membrane formation, with some needing enucleation to alleviate discomfort.

Study Methods

  • The researchers carried out a retrospective study on sixteen adult horses, aged between 9 and 25 years, showing evidence of the disease. They collected information from medical records including the horses’ signalment, clinical signs, duration and response to previous treatments, findings from ophthalmic examinations, postreferral treatment, response, and outcome.
  • The first signs observed in the horses affected by HIK were blepharospasm (uncontrollable twitching of the eyelid), epiphora (excessive tearing), and/or corneal opacification. Common findings at the time of referral comprised pigmented keratic precipitates (KPs), corneal edema, iris depigmentation, and retrocorneal membrane formation.
  • The horses received treatment in the form of topical and/or systemic anti-inflammatories and antibiotics, with varying degrees of success. An observed trend was that reducing or stopping anti-inflammatory therapy led to worsening of clinical signs and disease progression. This led to the need for enucleation (surgical removal of the eyeball) in eight of the affected eyes.

Key Findings

  • The researchers documented histopathology changes such as loss and dispersion of iris pigment, retrocorneal fibrous membrane formation, and keratitis (inflammation of the cornea).
  • The team also noted varying degrees of lymphoplasmacytic inflammation characterized by T-cell dominance within the corneal stroma, retrocorneal fibrous membrane, iris, and ciliary body with occasional presence of multinucleated giant cells.
  • In conclusion, the research characterized heterochromic iridocyclitis with secondary keratitis by uveal inflammation along with pigment dispersion and suspected corneal endothelial dysfunction. It underscored the importance of rigorous and frequent follow-up examinations as well as intensive local immune suppression to manage the disease. Despite best efforts in treatment, the study highlighted that HIK may not respond to therapy and enucleation may ultimately be needed to maintain the horse’s comfort.

Cite This Article

APA
Pinto NI, McMullen RJ, Linder KE, Cullen JM, Gilger BC. (2014). Clinical, histopathological and immunohistochemical characterization of a novel equine ocular disorder: heterochromic iridocyclitis with secondary keratitis in adult horses. Vet Ophthalmol, 18(6), 443-456. https://doi.org/10.1111/vop.12234

Publication

ISSN: 1463-5224
NlmUniqueID: 100887377
Country: England
Language: English
Volume: 18
Issue: 6
Pages: 443-456

Researcher Affiliations

Pinto, Nelson I
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27606, USA.
McMullen, Richard J
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27606, USA.
  • Pferdeklinik Munich-Riem, Munich, 81929, Germany.
Linder, Keith E
  • Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27606, USA.
Cullen, John M
  • Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27606, USA.
Gilger, Brian C
  • Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, 27606, USA.

MeSH Terms

  • Animals
  • Cornea / pathology
  • Female
  • Horse Diseases / diagnosis
  • Horse Diseases / pathology
  • Horses
  • Iridocyclitis / diagnosis
  • Iridocyclitis / pathology
  • Iridocyclitis / veterinary
  • Keratitis / diagnosis
  • Keratitis / pathology
  • Keratitis / veterinary
  • Male
  • Uvea / pathology

Citations

This article has been cited 6 times.
  1. Geiger T, Gerhards H, Bjelica B, Mackenthun E, Wollanke B. Analysis of 1840 Equine Intraocular Fluid Samples for the Presence of Anti-Leptospira Antibodies and Leptospiral DNA and the Correlation to Ophthalmologic Findings in Terms of Equine Recurrent Uveitis (ERU)-A Retrospective Study. Vet Sci 2022 Aug 21;9(8).
    doi: 10.3390/vetsci9080448pubmed: 36006363google scholar: lookup
  2. Wollanke B, Gerhards H, Ackermann K. Infectious Uveitis in Horses and New Insights in Its Leptospiral Biofilm-Related Pathogenesis. Microorganisms 2022 Feb 7;10(2).
  3. Slenter IJM, Hermans H, Ensink JM, Willems DS, Veraa S, Grinwis GCM, Boevé MH. Clinical, ultrasonographic, and histopathologic findings in seven horses with Descemet's membrane detachment: A case series. Vet Ophthalmol 2020 Jan;23(1):181-189.
    doi: 10.1111/vop.12710pubmed: 31544302google scholar: lookup
  4. Fischer BM, McMullen RJ Jr, Reese S, Brehm W. Intravitreal injection of low-dose gentamicin for the treatment of recurrent or persistent uveitis in horses: Preliminary results. BMC Vet Res 2019 Jan 16;15(1):29.
    doi: 10.1186/s12917-018-1722-7pubmed: 30651102google scholar: lookup
  5. Preston JF, Mustikka MP, Priestnall SL, Dunkel B, Fischer MC. Clinical features and outcomes of horses presenting with presumed equine immune mediated keratitis to two veterinary hospitals in the United Kingdom and Finland: 94 cases (2009-2021). Equine Vet J 2025 May;57(3):598-610.
    doi: 10.1111/evj.14213pubmed: 39183684google scholar: lookup
  6. Morén S, Kallberg M, Strom L. Equine uveitis: Outcome and adverse effects after one or two intravitreal low-dose gentamicin injections. Equine Vet J 2025 Jan;57(1):160-168.
    doi: 10.1111/evj.14056pubmed: 38329024google scholar: lookup